Warpehoski; Martha A.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Warpehoski; Martha A..The latest application filed is for "substituted aminoethers for the treatment of alzheimer's disease".

Company Profile

0.10.3

Warpehoski; Martha A. - Portage MI
Warpehoski; Martha A. - Comstock Township MI
Warpehoski; Martha A. - Kalamazoo MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Substituted Aminoethers for the Treatment of Alzheimer's Disease App 20090291970 - Beck; James P. ; et al.	2009-11-26
Substituted aminoethers for the treatment of Alzheimer's disease Grant 7,566,730 - Beck , et al. July 28, 2	2009-07-28
3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents Grant 7,034,049 - Pevarello , et al. April 25, 2	2006-04-25
Substituted amino carboxamides for the treatment of Alzheimer's disease Grant 6,962,934 - Warpehoski , et al. November 8, 2	2005-11-08
Alpha-hydroxy,-amino And -fluoro Derivatives Of Beta-sulphonyl Hydroxamic Acids As Matrix Metalloproteinases Inhibitors App 20030166687 - WARPEHOSKI, MARTHA A. ; et al.	2003-09-04
Substituted amino carboxamides for the treatment of alzheimer's disease App 20030166580 - Warpehoski, Martha A. ; et al.	2003-09-04
.alpha.-hydroxy, -amino, and halo derivatives of .beta.-sulfonyl hydroxamic acids as matrix metallopropteinases inhibitors Grant 6,437,177 - Warpehoski , et al. August 20, 2	2002-08-20
3(5)-ureido-pyrazole derivatives process for their preparation and their use as antitumor agents Grant 6,387,900 - Pevarello , et al. May 14, 2	2002-05-14
3(5)-amino-pyrazole derivatives, process for their preparation and their use as antitumor agents Grant 6,218,418 - Pevarello , et al. April 17, 2	2001-04-17
.beta.-sulfonyl hydroxamic acids Grant 5,847,153 - Warpehoski , et al. December 8, 1	1998-12-08
.alpha.-Amino sulfonyl hydroxamic acids as matrix metalloproteinase inhibitors Grant 5,804,593 - Warpehoski , et al. September 8, 1	1998-09-08
1,2,8,8a-tetrahydrocyclopropa (C) pyrrolo [3,2-e)]-indol-4(5H)-ones and related compounds Grant 4,978,757 - Kelly , et al. December 18, 1	1990-12-18
1,2,8,8A-tetrahydrocyclopropa(c)pyrrolo(3,2-e)-indol-4-(5H)-ones and related compounds Grant 4,912,227 - Kelly , et al. March 27, 1	1990-03-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.